Furthermore, the ability of α4-1BB treatment to promote proliferation and IFN-γ production in vitro and in vivo is abrogated in antigen-specific GPX4–/– CD8+ T cells compared with WT T cells from tumor-bearing mice. The gene discussed is CD8A; the disease is neoplasm.